Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

BACKGROUND: Co-located hepatitis C treatment at syringe service programs (SSP) is an emerging model of care for people who inject drugs (PWID). Implementation of these models can be informed by understanding the program costs. METHODS: We conducted an economic evaluation of a hepatitis C treatment i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapadia, Shashi N, Eckhardt, Benjamin J, Leff, Jared A, Fong, Chunki, Mateu-Gelabert, Pedro, Marks, Kristen M, Aponte-Melendez, Yesenia, Schackman, Bruce R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836210/
https://www.ncbi.nlm.nih.gov/pubmed/36644226
http://dx.doi.org/10.1016/j.dadr.2022.100109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836210/
https://www.ncbi.nlm.nih.gov/pubmed/36644226
http://dx.doi.org/10.1016/j.dadr.2022.100109

Ejemplares similares